Fadogia Agrestis: Clinical Evidence & Substantiation Summary
What Is Fadogia Agrestis?
Fadogia agrestis is a West African shrub traditional used for vitality and hormone support. While animal data is very strong, human clinical evidence is currently in its early stages but showing significant promise.
Mechanism of action: Preclinical studies suggest saponins in Fadogia stimulate Leydig cell activity in the testes, increasing steroidogenesis. It may also increase levels of LH (Luteinizing Hormone), the signal from the brain to produce testosterone.
Clinical Evidence Summary
Below are 3 key clinical studies on Fadogia Agrestis. Nutra Comp analyses 8+ studies in its full clinical evidence report.
Hormonal effects of Fadogia in animal models
Population: Rodent model
Key finding: Fadogia extract significantly increased serum testosterone and increased sexual behavioral markers. Note: Human trials are needed to confirm these results.
Fadogia and vitality biomarkers: case series
Population: N=12 self-reporting users
Key finding: Users reported significant improvements in energy and strength. No abnormalities in acute safety markers (ALT, AST) were noted at 600 mg/day.
Safety and toxicity of Fadogia agrestis: toxicology review
Population: Animal data
Key finding: High doses (>100 mg/kg in rodents) showed potential markers of kidney stress. High-dose supplementation (>1,000 mg in humans) should be avoided until further human safety data is available.
Evidence-Based Structure–Function Claims
Sample FDA-compliant structure–function claims generated by Nutra Comp, each linked to clinical evidence and scored for confidence.
Get the full substantiation report for Fadogia Agrestis
Includes all 8+ clinical studies analysed, complete claims library, and a ready-to-file substantiation memo.
Join Waitlist for Full AccessRelated Ingredients
Key Terms
Frequently Asked Questions
Is Fadogia Agrestis FDA approved?
Fadogia is sold as a dietary supplement under DSHEA. It does not require FDA drug approval and remains at 'investigational' status for many clinicians.
Should I cycle Fadogia?
Due to the early nature of the safety data and potential for adaptational resistance, many experts recommend cycling Fadogia (e.g., 5 days on, 2 days off) and taking periodic breaks from the supplement.
What is the most effective dose?
Most practitioners and emerging protocols use 300 mg to 600 mg per day. Do not exceed the suggested serving size on the product label.
Stop Spending Weeks on Substantiation
Nutra Comp generates full clinical evidence reports, FDA-compliant structure–function claims, and substantiation memos in minutes — not months.
Join the Waitlist